Treatment of cancer with an anti-KIR antibody: a patent evaluation of US9879082 and US2018208652
{{output}}
Introduction: KIR is an inhibitory receptor expressed by natural killer cells that suppress the immune response against tumor cells. There is a great need to discover and develop new therapies focused on inhibiting the action of KIR and consequently improving ... ...